PostEra

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

COVID
#1
#2

Sadly, masitinib carries with it a potential risk of ischemic heart disease:

#3

Thanks for the update. Not the best potential treatment if heart issues crop up.